Citius Oncology (CTOR) Form 3 TenX Keane Acquisition / Dahe Zhang ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Zhang Dahe

(Last) (First) (Middle)

C/O TENX KEANE ACQUISITION

420 LEXINGTON AVENUE, SUITE 2446

(Street)

NEW YORK NY 10170

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/13/2022

3. Issuer Name and Ticker or Trading Symbol
TenX Keane Acquisition [ TENKU ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	1,725,000(1)(2)	I	By 10XYZ Holdings LP

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. There ordinary shares reported in Table I include up to 225,000 ordinary shares that are subject to forfeiture by 10XYZ Holdings LP (the "Sponsor") depending on the extent to which the underwriters of the initial public offering of the issuer's securities do not exercise their over-allotment option in full as described in the issuer's registration statement on Form S-1 (File No. 333-256271), as amended.

2. The Sponsor is the record holder of the ordinary shares reported herein. Mr. Dahe Zhang, Director and Chief Financial Officer of the issuer, is a managing member of 10XYZ Management LLC, the general partner of the Sponsor, and has voting and investment power over the securities held by the Sponsor, and may be deemed to have beneficial ownership of the ordinary shares of the issuer held of record by the Sponsor. However, Mr. Zhang disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest.

	/s/ Dahe Zhang	10/13/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.